Cell Therapeutics said it intends to use net proceeds from the offering for general corporate purposes, including paying interest on or retiring outstanding debt and funding research and development, preclinical and clinical trials, and the preparation and filing of new drug applications.

FORBES: Cell Therapeutics Shares Decline on Offering News

Starting in July, Mr. Kerbel's new company, Practice LLC, will offer courses in five areas: academic preparation, career development, language and cultural orientation, software and library research skills and personal performance.

WSJ: B-Schools Try to Make Transition Smoother for International Students